What is Non-Alcoholic Fatty Liver Disease (NAFLD)?
Baylor College of Medicine - A Future Without Liver Disease
One-time treatment rescues lethal metabolic liver disease in mice
Dr. Hashem El-Serag on THCCC
Metabolic Syndrome and Severe Obesity Conference - Session One
Building A Team - Meet Dr. Todd K. Rosengart
Changing Epidemiology of Hepatocellular Carcinoma
17th International Virtual Round Table featuring Dr. Samer Mattar
Primary Biliary Cholangitis - An interview with John Vierling (part 2 - emerging treatment)
Vierling Part 1
Telfer B. Reynolds Lecture: Ascites, HRS & Portal Hypertension
Texas Collaborative Center for Hepatocellular Cancer: Third Annual Multi-Stakeholder Symposium
Texas Collaborative Center for Hepatocellular Cancer: Third Annual Multi Stakeholder Symposium 1
Autoimmune Diseases Explained
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk
Metabolic Syndrome and Severe Obesity Conference - Session Four
Vierling Part 3
Metabolic Syndrome and Severe Obesity Conference - Session Three
What is Liver Disease
Concerning Effects of Early-Life BPA Exposure and Fatty Liver